<DOC>
	<DOCNO>NCT00465543</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy new treatment nasal polyp compare placebo ( inactive substance ) . The treatment involve mint tea high rosmarinic acid . Rosmarinic acid polyphenol , chemical substance find certain plant oregano , rosemary , mint . It active ingredient spearmint . The placebo use study mint tea low rosmarininc acid . In trial amount rosmarinic acid high rosmarinic acid tea , study tea , 150mg . The placebo , low rosmarinic acid tea , contain 10mg rosmarinic acid .</brief_summary>
	<brief_title>Mint Tea Treatment Nasal Polyps</brief_title>
	<detailed_description>Nasal polyp clear , glisten , grape-like structure occur two percent adult contain large number activate eosinophils - 20 % constituent nasal polyp tissue . The standard treatment nasal polyp patient intranasal steroid , troublesome case , may follow short course oral steroid . Surgery reserve extremely large polyp fail medical treatment . However , many patient tire use nasal spray trouble side effect nasal irritation bleeding . So , treatment offer benefit , gold standard . Rosmarinic acid categorize polyphenolia phytochemical , 'plant phenol ' found variety plant include herbs oregano rosemary , well mint . Peppermint one widely use single ingredient herbal tea . It find vitro significant antimicrobial antiviral property , strong antioxidant antitumor action , antiallergenic ability . Human base research limit . A mint tea high rosmarinic acid recently produce . Anecdotal evidence suggest may beneficial allergic rhinitis take prior allergen exposure ( personal communication ) . Other anecdotal evidence find blunt sputum eosinophil follow allergen challenge allergic asthmatic ( personal communication ) . This trial aim study effect mint tea high rosmarinic acid adult bilateral nasal polyp , condition characterize chronic eosinophilic inflammation . The control treatment mint tea low rosmarinic acid .</detailed_description>
	<mesh_term>Polyps</mesh_term>
	<mesh_term>Nasal Polyps</mesh_term>
	<mesh_term>Rosmarinic acid</mesh_term>
	<criteria>1 . Subjects male female age 18 year old . 2 . Subjects sign informed consent agreement . 3 . Subjects history nasal polyp symptom previous 12 month . 1 . Subjects severe nasal polyp require immediate surgery . 2 . Subjects present unilateral polyp . 3 . Subjects undergone surgery treat nasal polyp ( nasal polypectomy ) within one year prior visit one . 4 . Subjects know fungal infection nose and/or paranasal sinus , nasal candidiasis , acute chronic infectious sinusitis viral bacterial nature . 5 . Subjects upper respiratory tract infection within two week prior Visit one time Visit 1 Visit 2 . 6 . Subjects cystic fibrosis , Young 's syndrome , primary ciliary dyskinesia , know HIV infection alcohol abuse . 7 . Subjects clinically significant , uncontrolled evidence cardiovascular , neurological , hepatic , renal , respiratory , medical condition may interfere study . 8 . Subjects recent history ( within six month ) clinically significant psychiatric disorder mild depression . 9 . Subjects clinically relevant deviation normal general physical examination . 10 . Subjects receive depot , systemic oral corticosteroid previous three month prior start study . 11 . Subjects unable cease treatment intranasal steroid four week prior Visit one . 12 . Subjects know hypersensitivity mint . 13 . Females pregnant lactate likely become pregnant study le 8 week postpartum . Women childbearing age may include opinion investigator , take adequate contraceptive measure . 14 . Subjects unable follow instruction within protocol know inability attend clinic visit within interval state . 15 . Subjects participate clinical trial involve investigational market drug within four week visit one . 16 . Subjects allergy skin test positive seasonal allergen present perform trial , cause , within past 2 year , clinically significant deterioration nasal symptom .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Nasal polyposis</keyword>
	<keyword>Mint tea</keyword>
	<keyword>Double-blind</keyword>
	<keyword>Placebo-controlled</keyword>
	<keyword>Crossover</keyword>
</DOC>